- Home
- RLMD vs WATT Comparison
RLMD vs WATT Comparison
Compare RLMD & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- WATT
- Stock Information
- Founded
- RLMD 2004
- WATT 2012
- Country
- RLMD United States
- WATT United States
- Employees
- RLMD N/A
- WATT N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- RLMD Health Care
- WATT Technology
- Exchange
- RLMD Nasdaq
- WATT Nasdaq
- Market Cap
- RLMD 11.5M
- WATT 10.0M
- IPO Year
- RLMD N/A
- WATT 2014
- Fundamental
- Price
- RLMD $0.38
- WATT $0.48
- Analyst Decision
- RLMD Hold
- WATT Strong Buy
- Analyst Count
- RLMD 4
- WATT 2
- Target Price
- RLMD $4.25
- WATT $2.25
- AVG Volume (30 Days)
- RLMD 881.7K
- WATT 18.4M
- Earning Date
- RLMD 03-18-2025
- WATT 11-12-2024
- Dividend Yield
- RLMD N/A
- WATT N/A
- EPS Growth
- RLMD N/A
- WATT N/A
- EPS
- RLMD N/A
- WATT N/A
- Revenue
- RLMD N/A
- WATT $431,184.00
- Revenue This Year
- RLMD N/A
- WATT $95.75
- Revenue Next Year
- RLMD N/A
- WATT $834.07
- P/E Ratio
- RLMD N/A
- WATT N/A
- Revenue Growth
- RLMD N/A
- WATT N/A
- 52 Week Low
- RLMD $0.34
- WATT $0.28
- 52 Week High
- RLMD $7.22
- WATT $2.75
- Technical
- Relative Strength Index (RSI)
- RLMD 27.23
- WATT 46.27
- Support Level
- RLMD $0.36
- WATT $0.46
- Resistance Level
- RLMD $0.49
- WATT $1.44
- Average True Range (ATR)
- RLMD 0.04
- WATT 0.16
- MACD
- RLMD 0.07
- WATT -0.05
- Stochastic Oscillator
- RLMD 12.64
- WATT 2.05
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.